Sanofi

Referências

  • 1. 07-07617 Tytgat GN Hyoscine butylbromide: a review of its use in the treatment of abdominal cramping and pain. Drugs 67 (9), 1343 - 1357 (2007).
  • 2. Paracetamol: mechanisms and updates https://academic.oup.com/bjaed/article/14/4/153/293533
  • 3. P13-08760 Lacy BE, Wang Fm Bowal S, Schaefer EOn-demand hyoscine butylbromide for the treatment of self-reported functional cramping abdominal pain. Scand J Gastroenterol 48 (8), 926 -935 (2013).
  • 4. P11- 06251 Mueller-Lissner S, Schaefer E, Kondla ASymptoms and their interpretation in patients self-treating abdominal cramping and pain with a spasmolytic (butylscopolamine bromide) - a pharmacy-based survey. Pharmacol Pharm 2, 82 - 87 (2011).
  • 5. Source: IMS OTC Analyzer Jun 2015
  • 6. P12-12472 Krueger D, Michael K, Allam S, Zeller F, Demir IE, Ceyhan G, Weiser T, Schemann MEffect of hyoscine butylbromide (Buscopan) on cholinergic pathways in the human intestine. 20th United Eur Gastroenterology week (UEGW), Amsterdam,20-24 Oct 2012
  • 7. Bowel Disorders. Brian E. Lacy et al. Gastroenterology 2016;150:1393–1407
  • 8. Epidemiological Study – Multi-Country – 2004 IPSOS
  • 9. Growth Potential Study – Multi-Country – ISM 2015
  • 10. Passos MDCF Diagnosis and Treatment. GED gastroenterol. endosc. Dig 2012; 31(2): 71-74
  • 11. Sampaio HAC. Nutritional aspects related to the menstrual cycle. Rev Nutr 2002; 15(3): 309-317
  • 12. RCM Buscopan
  • 13. Nicholas Hall’s global OTC Database, DB6

Utilizamos cookies próprios e de terceiros para proporcionar-lhe um acesso melhor e personalizado ao site, bem como mostrar-lhe publicidade relacionada com as suas preferências de navegação. Ao clicar em “aceito” está a consentir o uso de cookies.

Carregue aqui para saber mais OK